CJC-1295 / Ipamorelin
Ipamorelin Injection Timing: The Fasted-State Requirement Explained
Why insulin levels at injection time control GH pulse amplitude, the two optimal windows (morning fasted, bedtime), how long to wait before eating after injection, and why timing matters less for CJC-1295 with DAC.
Informational only. Not medical advice. Consult a licensed healthcare provider before starting, changing, or stopping any protocol.
Why timing is critical for Ipamorelin (and GH secretagogues generally)
Ipamorelin and CJC-1295 (no DAC) trigger a GH pulse from the pituitary. The size of that pulse — the peak GH concentration achieved — depends on insulin levels at the time of injection. Insulin and GH have an antagonistic relationship at the pituitary: elevated insulin suppresses GH secretion.
This is not a subtle effect. Studies on GHRP compounds show that GH pulse amplitude can be reduced by 50–70% when insulin is elevated versus when fasting. Timing your injection correctly is the single highest-leverage thing you can do to maximize the return from a CJC-1295/Ipamorelin protocol.
The two optimal windows
GH secretagogues are ideally injected when insulin is at its lowest:
- First thing in the morning (fasted state): After an overnight fast, insulin is at its lowest point of the day. This is the most reliable and highest-amplitude window for most users. Inject before eating or drinking anything other than water.
- At bedtime (2+ hours after last meal): The most physiologically relevant window — natural GH secretion peaks during slow-wave sleep, and injecting CJC-1295/Ipamorelin at bedtime amplifies that natural nocturnal pulse. Requires strict 2-hour post-meal fast; if you ate late, skip this dose rather than inject into an insulin-elevated state.
What "fasted state" means in practice
| Situation | Inject now? | Reason |
|---|---|---|
| 8+ hours since last meal, morning | Yes — optimal | Lowest insulin of the day |
| 2+ hours since a small meal | Acceptable | Insulin partially cleared; reduced but not minimal suppression |
| 1–2 hours after a meal | Suboptimal | Insulin still meaningfully elevated; pulse amplitude reduced |
| 30 min after a meal | Avoid | Peak insulin; significant pulse suppression expected |
| After a high-carb meal | Avoid; wait 3+ hours | High-carb meals produce larger, longer insulin spikes |
How long to wait before eating after injection
After injecting CJC-1295 (no DAC) + Ipamorelin, the GH pulse peaks within 15–45 minutes and substantially resolves within 60–90 minutes. Most practitioners recommend waiting at least 30 minutes after injection before eating to allow the pulse to complete in a low-insulin environment. A 30–60 minute post-injection fast is a reasonable standard.
Multiple daily doses: timing each one
Some protocols call for twice-daily CJC-1295/Ipamorelin. The timing windows for each dose are independent:
- Dose 1: morning fasted (before breakfast)
- Dose 2: bedtime fasted (2+ hours after dinner)
Midday dosing is possible but requires a 2-hour post-meal, 30-minute pre-meal window — practically challenging for most schedules. Morning + bedtime is the most common two-dose structure because both are naturally low-insulin windows.
CJC-1295 with DAC: timing matters less
If you're using CJC-1295 with DAC (once- or twice-weekly dosing), the fasted-timing requirement is much less critical. DAC provides continuous GHRH receptor stimulation across 6–8 days — a single injection's timing has minimal impact on average GH exposure over that window. Still preferable to inject in a fasted state as a general practice, but missing the window by a few hours isn't operationally significant with DAC.
Tracking injection time matters for GH secretagogues
For most peptides, logging "which day" is enough. For CJC-1295/Ipamorelin, time-of-day matters. My Pep Calc records timestamp with each dose log — so you can see whether your morning doses consistently land pre-breakfast and your evening doses are consistently 2+ hours post-meal.
If you're not seeing the expected results from a CJC-1295/Ipamorelin protocol, review your dose timestamps. Timing drift (injecting 30 minutes after breakfast "because that's when I remember") is a common reason for reduced protocol effectiveness.
See the full GH secretagogue mechanism guide for why the GHRH/ghrelin receptor dual pathway produces GH pulses and why insulin timing matters at the pituitary level.
Frequently asked questions
- When should I inject CJC-1295 and Ipamorelin?
- Inject in a fasted state — either first thing in the morning before eating, or at bedtime at least 2 hours after your last meal. Insulin suppresses GH secretion at the pituitary; elevated insulin at time of injection significantly reduces GH pulse amplitude. The bedtime window is particularly potent because it amplifies the natural nocturnal GH pulse.
- How long should I fast before injecting Ipamorelin?
- At least 2 hours after any meal. 8+ hours (overnight fast) is optimal for the morning dose. After a high-carbohydrate meal, insulin elevation lasts longer — wait 3+ hours. The goal is the lowest insulin level achievable before injection.
- How long after injecting CJC-1295/Ipamorelin can I eat?
- Wait at least 30 minutes after injection before eating. The GH pulse peaks within 15–45 minutes and substantially resolves in 60–90 minutes. A 30–60 minute post-injection fast allows the pulse to complete before insulin rises from food intake.
- Can I inject CJC-1295/Ipamorelin after a meal?
- Technically yes, but it significantly blunts the GH response. Injecting 30 minutes after a meal (peak insulin) can reduce GH pulse amplitude by 50–70% compared to a fasted injection. If you can't hit a fasted window, it's often better to skip that dose and inject at your next available fasted window rather than inject into an insulin-elevated state.
- Does timing matter for CJC-1295 with DAC?
- Less so than for the no-DAC form. CJC-1295 with DAC provides continuous GHRH receptor stimulation across 6–8 days — the single injection timing has minimal impact on average GH exposure over that window. Fasted injection is still preferable as a general practice, but it's not operationally critical the way it is for the no-DAC + Ipamorelin combination.
Sources
- Raun K, et al. Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol. 1998;139(5):552-561.
- Cordido F, et al. Massive growth hormone (GH) discharge in obese subjects after the combined administration of GH-releasing hormone and GHRP-6: evidence for a marked somatotroph secretory capability in obesity. J Clin Endocrinol Metab. 1993;76(4):819-823.
- Van Cauter E, et al. Roles of circadian rhythmicity and sleep in human hormonal regulation. Endocr Rev. 1997;18(5):716-738.
Stop doing this math by hand.
My Pep Calc runs reconstitution, dose tracking, site rotation, and half-life curves for your whole stack — not just one compound.
See the Founders offer →